Alector (ALEC) Cash from Investing Activities Growth (3y) (2021 - 2026)
Powered by 
Analysis
Alector (ALEC) Cash from Investing Activities Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | -39.19% |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | -177.73% |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 46.78% |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 66.14% |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | -44.69% |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | -246.81% |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | -72.08% |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 27.84% |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - | 40.69% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 40.69% |
| Mar 31, 2026 | -11.76% |
| Dec 31, 2025 | 11.67% |
| Sep 30, 2025 | -6.46% |
| Jun 30, 2025 | 30.97% |
| Mar 31, 2025 | 95.13% |
| Dec 31, 2024 | 31.66% |
| Sep 30, 2024 | 37.23% |
| Jun 30, 2024 | -13.09% |
| Mar 31, 2024 | -28.21% |
| Dec 31, 2023 | 16.08% |
| Sep 30, 2023 | -19.91% |
| Jun 30, 2023 | 4.11% |
| Mar 31, 2023 | 39.43% |
| Dec 31, 2022 | -15.12% |
| Sep 30, 2022 | 9.65% |
| Jun 30, 2022 | -119.30% |
| Mar 31, 2022 | 56.91% |
| Dec 31, 2021 | -76.04% |
| Sep 30, 2021 | -13.73% |